Chen P, Gupta K, Wells A
Department of Pathology, University of Alabama at Birmingham 35294.
J Cell Biol. 1994 Feb;124(4):547-55. doi: 10.1083/jcb.124.4.547.
The EGF receptor (EGFR) upon activation signals increased cell movement. However, the domains within the receptor, and the pathway which trigger movement are undefined. We expressed EGFR mutants at physiologic levels in receptor-devoid NR6 cells to investigate this biologic response. The receptors possessed kinase activity and underwent autophosphorylation as predicted by primary amino acid sequence. EGF-induced cell motility was assessed in vitro by excess migration into an acellular area and colony scatter in the presence of saturating concentrations of EGF. Wild-type (WT)-EGFR signaled increased motility. However, replacing the conserved lysine721 with methionine resulted in a kinase-inactive receptor which did not elicit movement. Removal of the entire terminus by truncation (c'973) also abrogated ligand-induced motility. Thus, we concentrated on the carboxy-terminal domains. EGF-induced movement was seen with a less-truncated mutant (c'1000) that contained a single autophosphorylated tyrosine (tyrosine992). Other mutants, c'991 and c'1000F992, in which this tyrosine was removed did not signal motility. Fusion mutants which presented other autophosphorylated tyrosine domains also exhibited EGF-induced movement. These findings suggested that the presence of both an autophosphorylated tyrosine signaling domain and the kinase activity are necessary for this biologic response. All kinase-positive mutants signaled cell proliferation but only those that contained autophosphorylatable tyrosines induced movement. The motility responses mediated by these EGFR were identical in the presence or absence of mitomycin-C, at a dose (0.5 micrograms/ml) which completely inhibited cell proliferation. On the other side, D-actinomycin (50 ng/ml) blocked EGF-induced motility but did not affect thymidine incorporation. Thus, EGF-induced mitogenesis and cell motility are mediated through different pathways.
表皮生长因子受体(EGFR)激活后会发出增加细胞运动的信号。然而,受体内部的结构域以及触发细胞运动的信号通路尚不明确。我们在缺乏受体的NR6细胞中以生理水平表达EGFR突变体,以研究这种生物学反应。这些受体具有激酶活性,并如一级氨基酸序列预测的那样发生了自身磷酸化。通过在无细胞区域的过度迁移以及在饱和浓度的表皮生长因子(EGF)存在下的集落散射,在体外评估了EGF诱导的细胞运动性。野生型(WT)-EGFR发出了增加运动性的信号。然而,将保守的赖氨酸721替换为甲硫氨酸会产生一种激酶失活的受体,该受体不会引发细胞运动。通过截短去除整个末端(c'973)也消除了配体诱导的运动性。因此,我们将重点放在了羧基末端结构域。用一个截短程度较小的突变体(c'1000)观察到了EGF诱导的运动,该突变体含有一个自身磷酸化的酪氨酸(酪氨酸992)。去除了该酪氨酸的其他突变体c'991和c'1000F992则不会发出运动信号。呈现其他自身磷酸化酪氨酸结构域的融合突变体也表现出EGF诱导的运动。这些发现表明,自身磷酸化的酪氨酸信号结构域和激酶活性的存在对于这种生物学反应都是必需的。所有激酶阳性的突变体都发出了细胞增殖信号,但只有那些含有可自身磷酸化酪氨酸的突变体才会诱导细胞运动。在存在或不存在丝裂霉素-C的情况下,这些EGFR介导的运动反应是相同的,丝裂霉素-C的剂量(0.5微克/毫升)可完全抑制细胞增殖。另一方面,放线菌素D(50纳克/毫升)可阻断EGF诱导但不影响胸腺嘧啶核苷掺入。因此,EGF诱导的有丝分裂和细胞运动是通过不同的信号通路介导的。